Phillip A. Horwitz

3.1k total citations
48 papers, 1.3k citations indexed

About

Phillip A. Horwitz is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Epidemiology. According to data from OpenAlex, Phillip A. Horwitz has authored 48 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Cardiology and Cardiovascular Medicine, 19 papers in Surgery and 15 papers in Epidemiology. Recurrent topics in Phillip A. Horwitz's work include Cardiac Valve Diseases and Treatments (14 papers), Infective Endocarditis Diagnosis and Management (13 papers) and Cardiac Imaging and Diagnostics (10 papers). Phillip A. Horwitz is often cited by papers focused on Cardiac Valve Diseases and Treatments (14 papers), Infective Endocarditis Diagnosis and Management (13 papers) and Cardiac Imaging and Diagnostics (10 papers). Phillip A. Horwitz collaborates with scholars based in United States, United Kingdom and Canada. Phillip A. Horwitz's co-authors include Saket Girotra, Rohan Khera, Ankur Vyas, Mary Vaughan‐Sarrazin, Wassef Karrowni, Peter Cram, Amgad Mentias, Samir Kapadia, Marwan Saad and Sidakpal Panaich and has published in prestigious journals such as Circulation, SHILAP Revista de lepidopterología and Journal of the American College of Cardiology.

In The Last Decade

Phillip A. Horwitz

47 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Phillip A. Horwitz United States 20 825 537 355 272 206 48 1.3k
Nicolas Mansencal France 22 930 1.1× 351 0.7× 176 0.5× 180 0.7× 468 2.3× 101 1.4k
Ayman Elbadawi United States 22 1.3k 1.6× 696 1.3× 487 1.4× 541 2.0× 256 1.2× 186 2.1k
Can Yücel Karabay Türkiye 21 906 1.1× 335 0.6× 161 0.5× 229 0.8× 313 1.5× 123 1.3k
Smadar Kort United States 19 1.1k 1.3× 618 1.2× 433 1.2× 293 1.1× 429 2.1× 66 1.9k
Anil Poulose United States 13 632 0.8× 338 0.6× 306 0.9× 122 0.4× 297 1.4× 49 1.0k
Balendu C. Vasavada United States 21 1.4k 1.7× 943 1.8× 778 2.2× 306 1.1× 164 0.8× 56 2.0k
Gian M. Novaro United States 20 1.3k 1.6× 372 0.7× 515 1.5× 550 2.0× 340 1.7× 51 1.7k
Carlos A. Moreno United States 15 922 1.1× 292 0.5× 510 1.4× 184 0.7× 315 1.5× 34 1.3k
Hussein El-Shafei United Kingdom 10 562 0.7× 304 0.6× 160 0.5× 177 0.7× 105 0.5× 15 1.0k
N. M. Bass New Zealand 9 712 0.9× 371 0.7× 654 1.8× 301 1.1× 218 1.1× 10 1.3k

Countries citing papers authored by Phillip A. Horwitz

Since Specialization
Citations

This map shows the geographic impact of Phillip A. Horwitz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Phillip A. Horwitz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Phillip A. Horwitz more than expected).

Fields of papers citing papers by Phillip A. Horwitz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Phillip A. Horwitz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Phillip A. Horwitz. The network helps show where Phillip A. Horwitz may publish in the future.

Co-authorship network of co-authors of Phillip A. Horwitz

This figure shows the co-authorship network connecting the top 25 collaborators of Phillip A. Horwitz. A scholar is included among the top collaborators of Phillip A. Horwitz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Phillip A. Horwitz. Phillip A. Horwitz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Vutthikraivit, Wasawat, et al.. (2024). Temporary-Permanent Pacemakers in the Management of Conduction Abnormalities in Patients Undergoing Transcatheter Aortic Valve Replacement. Journal of the Society for Cardiovascular Angiography & Interventions. 3(4). 101310–101310.
2.
Mentias, Amgad, Marwan Saad, Milind Y. Desai, et al.. (2021). Transcatheter Versus Surgical Aortic Valve Replacement in Patients With Rheumatic Aortic Stenosis. Journal of the American College of Cardiology. 77(14). 1703–1713. 13 indexed citations
3.
Nazif, Tamim, Jeffrey Moses, Rahul Sharma, et al.. (2021). Randomized Evaluation of TriGuard 3 Cerebral Embolic Protection After Transcatheter Aortic Valve Replacement. JACC: Cardiovascular Interventions. 14(5). 515–527. 65 indexed citations
4.
Mentias, Amgad, Milind Y. Desai, Marwan Saad, et al.. (2020). Management of Aortic Stenosis in Patients With End-Stage Renal Disease on Hemodialysis. Circulation Cardiovascular Interventions. 13(8). e009252–e009252. 24 indexed citations
5.
Mentias, Amgad, Marwan Saad, Milind Y. Desai, et al.. (2020). Driving Distance and Outcomes of Transcatheter Aortic Valve Replacement. JACC: Cardiovascular Interventions. 13(22). 2714–2716. 1 indexed citations
6.
Mentias, Amgad, Milind Y. Desai, Marwan Saad, et al.. (2020). Incidence and Outcomes of Acute Coronary Syndrome After Transcatheter Aortic Valve Replacement. JACC: Cardiovascular Interventions. 13(8). 938–950. 34 indexed citations
7.
Guedeney, Paul, Bimmer E. Claessen, Roxana Mehran, et al.. (2019). Small‐vessel PCI outcomes in men, women, and minorities following platinum chromium everolimus‐eluting stents: Insights from the pooled PLATINUM Diversity and PROMUS Element Plus Post‐Approval studies. Catheterization and Cardiovascular Interventions. 94(1). 82–90. 8 indexed citations
8.
Mentias, Amgad, Marwan Saad, Saket Girotra, et al.. (2019). Impact of Pre-Existing and New-Onset Atrial Fibrillation on Outcomes After Transcatheter Aortic Valve Replacement. JACC: Cardiovascular Interventions. 12(21). 2119–2129. 67 indexed citations
9.
Zahr, Firas, et al.. (2018). Transcatheter Double Valve Replacement of an Aortic and Mitral Valve in the Native Annulus. Operative Techniques in Thoracic and Cardiovascular Surgery. 23(4). 166–180. 1 indexed citations
10.
Batchelor, Wayne, David E. Kandzari, Scott Davis, et al.. (2017). Outcomes in Women and Minorities Compared With White Men 1 Year After Everolimus-Eluting Stent Implantation. JAMA Cardiology. 2(12). 1303–1303. 41 indexed citations
11.
Khera, Rohan, Peter Cram, Xin Lü, et al.. (2015). Trends in the Use of Percutaneous Ventricular Assist Devices. JAMA Internal Medicine. 175(6). 941–941. 106 indexed citations
12.
Khera, Rohan, Peter Cram, Mary Vaughan‐Sarrazin, Phillip A. Horwitz, & Saket Girotra. (2015). Use of Mechanical Circulatory Support in Percutaneous Coronary Intervention in the United States. The American Journal of Cardiology. 117(1). 10–16. 30 indexed citations
13.
Khera, Rohan, KellyAnn Light-McGroary, Firas Zahr, Phillip A. Horwitz, & Saket Girotra. (2015). Trends in hospitalization for takotsubo cardiomyopathy in the United States. American Heart Journal. 172. 53–63. 82 indexed citations
14.
Karrowni, Wassef, et al.. (2012). TCT-695 Single Versus Double Stenting for the Left Main Coronary Bifurcation: A Systematic Review and Meta-Analysis. Journal of the American College of Cardiology. 60(17). B202–B202. 3 indexed citations
15.
Girotra, Saket, Xin Lu, Ioana Popescu, et al.. (2010). The Impact of Hospital Cardiac Specialization on Outcomes After Coronary Artery Bypass Graft Surgery. Circulation Cardiovascular Quality and Outcomes. 3(6). 607–614. 5 indexed citations
16.
Lasala, John M., David A. Cox, Danielle Morris, et al.. (2009). Two-Year Results of Paclitaxel-Eluting Stents in Patients With Medically Treated Diabetes Mellitus from the TAXUS ARRIVE Program. The American Journal of Cardiology. 103(12). 1663–1671. 19 indexed citations
17.
Horwitz, Phillip A., et al.. (2008). Thrombocytopenia in Patients Treated with Heparin, Combination Antiplatelet Therapy, and Intra‐Aortic Balloon Pump Counterpulsation. Journal of Interventional Cardiology. 21(4). 350–356. 22 indexed citations
18.
Fasano, Mary Beth, et al.. (2007). Clopidogrel Desensitization Protocol for the Treatment of Thienopyridine Hypersensitivity. Critical Pathways in Cardiology A Journal of Evidence-Based Medicine. 6(1). 26–29. 11 indexed citations
19.
Herrmann, Howard C., Frank E. Silvestry, Ruchira Glaser, et al.. (2005). Percutaneous patent foramen ovale and atrial septal defect closure in adults: Results and device comparison in 100 consecutive implants at a single center. Catheterization and Cardiovascular Interventions. 64(2). 197–203. 28 indexed citations
20.
Herrmann, Howard C., Vincent See, Phillip A. Horwitz, et al.. (2003). Benefits of intracardiac echocardiography in the guidance of percutaneous transcatherter closure of atrial septal defect and patent foramen ovale. Journal of the American College of Cardiology. 41(6). 60–61. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026